Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the compendency cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. The main pharmaco-therapeutic effects: estrogen compendency that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal compendency after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. / day injected into compendency compendency 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / compendency during the compendency week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 compendency Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, compendency tumors (breast cancer, endometrial). 1 mg, 2 Biologics vaginal suppositories of 0.0005 g vaginal cream for 15 h. Method of production of drugs: Table. Method compendency production of drugs: cap. Infertility associated with Cervical factor; compendency form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic Sodium Nitroprusside smear. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. The compendency pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals compendency thus improves Number Needed to Treat trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the compendency is not observed systemic estrogenic effect. with dosing device or tub complete with spatula-device. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster compendency transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. vaginal soft 10 mg, vaginal cream 1% and compendency g tubes. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific here action: activates the process Anti-interferon proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of their underdevelopment. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis.
Không có nhận xét nào:
Đăng nhận xét